Silver Molybdate Nanoparticles for Enhanced Tumor Immunotherapy through Pyroptosis Conversion and Ferroptosis Induction
Angewandte Chemie International Edition · 25.04.2025 · 64 (18)
DOI: 10.1002/anie.202501530 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 25.02.2025. Verfasst von Hao Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, P.…. Hauptthemen laut MEDLINE: Pyroptosis, Molybdenum, Ferroptosis, Immunotherapy. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science and Technology Development Planning Project of Jilin Province.
Abstract (Originalsprache)
Pyroptosis holds great potential in tumor therapy due to its strong immunogenicity. Several strategies, including ion interference therapy (IIT), are developed to induce pyroptosis. However, the mechanism by which metal oxoanions induced pyroptosis remained unclear. It was reported that MoO 4 2− ions could stimulate immune responses, but their pyroptosis‐inducing mechanisms were not fully understood. Herein, we synthesized uniform and dispersed silver molybdate (Ag 2 MoO 4 ) nanoparticles (AMO) via a solvothermal method. AMO responded to H 2 O 2 and glutathione (GSH) stimuli, releasing Ag + and MoO 4 2− ions, generating reactive oxygen species (ROS), and depleting GSH, thereby inducing ferroptosis and pyroptosis. The MoO 4 2− also inhibited cell migration and upregulated GSDME expression, converting apoptosis into caspase‐3/GSDME‐mediated pyroptosis. Additionally, DNA damage and ROS activated the cGAS‐STING pathway, enhancing innate immunity. In vivo experiments demonstrated that the combination of AMO and the immune checkpoint inhibitor αPD‐1 significantly inhibited tumor growth. This combination promoted dendritic cells (DCs) maturation, increased effector T cell numbers, induced M1 macrophage polarization, and alleviated immunosuppression. This study contributed to a deeper understanding of metal oxoanion‐mediated pyroptosis, supporting its potential application in cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, P. R. China.
- School of Applied Chemistry and Engineering, University of Science and Technology of China, Hefei, 230026, P. R. China.
- Key Laboratory of Superlight Materials & Surface Technology of Ministry of Education, College of Material Sciences and Chemical Engineering, Harbin Engineering University, Harbin, 150001, P. R. China.
ORCID-Profile: Ping'an Ma
Förderung
- National Natural Science Foundation of China
- Science and Technology Development Planning Project of Jilin Province
Zitieren
APA
Chen, H., Ding, B., Tan, J., Meng, Q., Li, J., Zhang, W., Zheng, P., Liu, B., Ma, P., & Lin, J. (2025). Silver Molybdate Nanoparticles for Enhanced Tumor Immunotherapy through Pyroptosis Conversion and Ferroptosis Induction. Angewandte Chemie International Edition, 64(18). https://doi.org/10.1002/anie.202501530
Vancouver
Chen H, Ding B, Tan J, Meng Q, Li J, Zhang W, et al. Silver Molybdate Nanoparticles for Enhanced Tumor Immunotherapy through Pyroptosis Conversion and Ferroptosis Induction. Angewandte Chemie International Edition. 2025;64(18). doi:10.1002/anie.202501530
BibTeX
@article{Chen2025,
author = {Chen, Hao and Ding, Binbin and Tan, Jia and Meng, Qi and Li, Jing and Zhang, Wenying and Zheng, Pan and Liu, Bin and Ma, Ping'an and Lin, Jun},
title = {Silver Molybdate Nanoparticles for Enhanced Tumor Immunotherapy through Pyroptosis Conversion and Ferroptosis Induction},
journal = {Angewandte Chemie International Edition},
year = {2025},
volume = {64},
number = {18},
doi = {10.1002/anie.202501530}
}
EUVIMED